Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological analysis of infectious disease in border port areas of Heilongjiang Province, 2014-2023.

BMC public health·2026
Same author

Diagnostic Yield of Fecal Immunochemical Test for Advanced Colorectal Neoplasms in Adults Under 50: A Single-Center Cohort in Taiwan.

Journal of clinical medicine·2026
Same author

Integrating genetic and lifestyle determinants in a risk prediction model for esophageal squamous cell carcinoma in Taiwan.

Scientific reports·2026
Same author

A CD54-targeted magneto-responsive nanotheranostic for precision treatment of viral pneumonia via CTSB-mediated PANoptosis inhibition.

Journal of nanobiotechnology·2026
Same author

Prognostic comparison of endoscopic submucosal dissection versus surgery for undifferentiated early gastric cancer: a Taiwan multicenter study.

Surgical endoscopy·2026
Same author

Inhibiting SHP2 improves ventricular remodeling by restoring AMPK phosphorylation and mitochondrial homeostasis.

Cell communication and signaling : CCS·2026

Related Experiment Video

Updated: Jan 17, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K

Humanized Immune Mouse Models: Emerging Applications for Cancer Immunotherapy.

Yu-Sen Zhong1, Wei Xie1,2, Xue-Jian Li1,2

  • 1Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou 310013, China.

Endocrine, Metabolic & Immune Disorders Drug Targets
|September 15, 2025
PubMed
Summary

Severe Combined Immunodeficient (SCID) mice engrafted with human cells offer improved preclinical models for cancer immunotherapy. These humanized immune system mouse models better predict clinical trial outcomes by mimicking human immune responses.

Keywords:
CD45<sup>+</sup> cellsHumanized immune mousechimeric rategraft versus host disease.hematopoietic stem cell

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.3K

Related Experiment Videos

Last Updated: Jan 17, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.8K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

15.3K

Area of Science:

  • Immunology
  • Oncology
  • Preclinical Research

Background:

  • Conventional mouse models inadequately replicate human immune responses, leading to discrepancies between preclinical findings and clinical trial results.
  • Severe Combined Immunodeficient (SCID) mice allow for the reconstitution of human immune cells, addressing limitations of traditional models.

Purpose of the Study:

  • To review advancements and challenges in SCID and humanized immune system mouse models for immuno-oncology research.
  • To highlight the utility of these models in evaluating human-specific immunotherapies and understanding tumor microenvironments.

Main Methods:

  • Engraftment of human CD34+ hematopoietic cells, peripheral blood mononuclear cells, organoids, or fetal tissues into SCID mice (e.g., NSG, NCG, NXG).
  • Utilizing SCID mice with human immune cell populations exceeding 25% to study human innate immunity, viral infections, and xenografts.

Main Results:

  • Humanized SCID mice support the development of human cancer xenografts and enable investigation of human tumor-immune microenvironments.
  • These models facilitate the evaluation of human-specific immunotherapies like CAR-T, CAR-NK, and immune checkpoint inhibitors.

Conclusions:

  • Humanized SCID mouse models are crucial for advancing immuno-oncology research, despite challenges like graft-versus-host disease and short experimental durations.
  • These models enhance the reliability of preclinical efficacy testing for tumor immunotherapies, bridging the gap between mouse studies and clinical outcomes.